NIH-funded research Sbir 2 grant

Wearable device and phone app to monitor myasthenia gravis symptoms

Official title: Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis

Funded at Biosensics, LLC · NIH-11237038 · Data updated 2026-11-12

A wearable sensor and mobile app will continuously track muscle weakness, speech changes, and drooping eyelids for people with myasthenia gravis.

More Myasthenia Gravis research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionBiosensics, LLC
NIH-funded
Lab location1 site (Newton, UNITED STATES)
Project startSeptember 15, 2022
Project endNovember 30, 2026
Funding year2026
Award (this year)$973,917
NIH project number5R44NS122672-03
Project IDNIH-11237038 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a confirmed diagnosis of myasthenia gravis who experience fluctuating muscle weakness, speech changes, or eyelid drooping and who can use a wearable device and smartphone app are ideal candidates.

Less likely to help

People without MG, those unable to wear sensors or use a smartphone, or those with conditions that interfere with reliable sensor or speech data may not benefit.

What this research studies

You would wear a small sensor (MGWear) that gathers movement and function data while a mobile app records speech and facial signs like ptosis. The devices send data securely to a HIPAA-compliant cloud where algorithms analyze symptom patterns and fluctuations over time. BioSensics is working with Massachusetts General Hospital and the MGNet consortium to collect patient data and refine the measurements. The system is being validated against clinic exams to see if it captures symptom changes between visits.

Why it matters

Potential benefit: If successful, this could help you and your care team monitor MG symptoms from home, detect worsening sooner, and tailor treatments more precisely.

How similar studies have gone: Wearable monitoring and speech-analysis approaches have shown promise in other neurologic diseases, but continuous remote monitoring specifically for MG is relatively new and still being validated.

Where this research is happening

  • Biosensics, LLC
    Newton, United States
    Active

Researchers

  • Principal investigator: Vaziri, Ashkan — Biosensics, LLC
  • Study coordinator: Vaziri, Ashkan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.